Stocks · Health care · Pharmaceutical Preparations

GENELUX Corp

GNLX Clue Score27

United States Fiscal year ends December CIK 0001231457 Results filed 25 Mar 2025

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

John Thomas

1 Jun 2026

Director

Sold on a plan

10,000

$2.98

$29.80K

John Thomas

2 Mar 2026

Director

Sold on a plan

10,000

$2.90

$28.96K

John Thomas

1 Dec 2025

Director

Sold on a plan

10,000

$5.00

$50.01K

James L Tyree

11 Sep 2024

Director

Sold on a plan

1,730

$2.60

$4.50K

Show all 152 transactions →

What was left out

Form 4 filings counted 166

Amendments (4/A) skipped 5

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 10

Sales at will 128

Transactions with no price 9

Shares from compensation/vesting 4,605,497

History held since 30 Jan 2023